Please assess the completion status of the following clinical trial:

Trial Title: Sitagliptin Versus Glipizide in Participants With Type 2 Diabetes Mellitus and Chronic Renal Insufficiency (MK-0431-063 AM1)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Has type 2 diabetes mellitus~* Has moderate or severe renal insufficiency~Exclusion Criteria:~* Has type 1 diabetes mellitus or a history of ketoacidosis~* Is on a new weight loss program~* Has active liver disease~* Is on dialysis or is likely to need dialysis during the study

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Sitagliptin (Type: EXPERIMENTAL): Sitagliptin + Placebo for Glipizide
- Glipizide (Type: ACTIVE_COMPARATOR): Glipizide + Placebo for Sitagliptin

Based on this trial design, predict the completion outcome and termination type (if applicable).